ScholarIQanswers from OpenAlex & ORCID
Scott North
ResearcherPublications, citations & collaboration network
Scott North is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Scott North have?
ScholarIQindexed works
Scott North has 302 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Scott North have?
ScholarIQcitation count
Scott North has 19,146 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Scott North?
ScholarIQh-index
Scott North has an h-index of 53 in OpenAlex.
What is the i10-index of Scott North?
ScholarIQi10-index
Scott North has an i10-index of 134 in OpenAlex.
What is the ORCID of Scott North?
ScholarIQorcid
The ORCID for Scott North is on the source record.
What is the OpenAlex record for Scott North?
ScholarIQopenalex
The OpenAlex for Scott North is on the source record.
What are the most-cited papers on Scott North?
ScholarIQmost cited works
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N., Robert J. Jones, Oscar B. Goodman, Fred Saad, John Staffurth, Paul N. Mainwaring, Stephen Harland, Thomas W. Flaig, Thomas E. Hutson, Tina Cheng, Helen Patterson, John D. Hainsworth, Charles J. Ryan, Cora N. Sternberg, Susan Ellard, Aude Fléchon, Mansoor N. Saleh, Mark C. Scholz, Eleni Efstathiou, Andrea Zivi, Diletta Bianchini, Yohann Loriot, Nicole Chieffo, Thian Kheoh, Christopher M. Haqq, Howard I. Scher
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, Mark Warren, Ali Golshayan, Chakshu Sahi, Bernhard J. Eigl, Joseph D. Ruether, Tina Cheng, Scott North, Peter Venner, Jennifer J. Knox, Kim N., Christian Kollmannsberger, David F. McDermott, William Oh, Michael B. Atkins, Ronald M. Bukowski, Brian I. Rini, Toni K. Choueiri
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
Ian D. Davis, Andrew Martin, Martin R. Stockler, Stephen Begbie, Kim N., Simon Chowdhury, Xanthi Coskinas, Mark Frydenberg, Wendy Hague, Lisa G. Horvath, Anthony M. Joshua, Nicola Jane Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott North, Francis Parnis, Wendy R. Parulekar, David Pook, M. Neil Reaume, Shahneen Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Emily Tu, Francisco Vera-Badillo, Scott Williams, Sonia Yip, Alison Y. Zhang, Robert Zielinski, Christopher J. Sweeney
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Homayoun Zargar, Patrick Espiritu, Adrian Fairey, Laura S. Mertens, Colin P. Dinney, Maria Carmen Mir, Laura-Maria Krabbe, Michael S. Cookson, Niels-Erik Jacobsen, Nilay Gandhi, Joshua Griffin, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, David Youssef, Évanguelos Xylinas, Nicholas Campain, Wassim Kassouf, Marc Dall’Era, Jo-An Seah, Cesar E. Ercole, Simon Horenblas, Srikala S. Sridhar, John McGrath, Jonathan Aning, Shahrokh F. Shariat, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeff M. Holzbeierlein, Trinity J. Bivalacqua, Scott North, Daniel A. Barocas, Yair Lotan, Jorge A. García, Andrew J. Stephenson, Jay B. Shah, Bas W. van Rhijn, Siamak Daneshmand, Philippe E. Spiess, Peter C. Black